NSEShareholders meeting1d ago · 17 Sept 2026, 07:51 pm

Shareholders meeting

Cohance Lifesciences Limited · COHANCE

✦ AI SummaryResults

Cohance Lifesciences Limited held its 8th Annual General Meeting on September 17, 2026, through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The meeting commenced at 04:00 p.m. (IST) and concluded at 5:21 p.m. (IST). The requisite quorum was present, and the meeting was called to order. The Chairman delivered his speech, and the members were informed about the Integrated Annual Report for the financial year 2025-26. The Statutory Auditors' Report and the Secretarial Auditor's Report do not contain any qualification, observation, or adverse remarks.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Cohance Lifesciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 17, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

Attachments (1)

📄

SUVENPHARMROHIT_17092026195109_Cohance_AGM_disclosure_17Sep26_.pdf

pdf

Download →
View document text
17 September 2026 To To National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra Kurla Complex 25th Floor, P. J. Towers, Bandra (E), Mumbai – 400 051 Dalal Street, Mumbai - 400 001 Scrip Symbol: COHANCE Scrip Code: 543064 Dear Sir/Madam, Sub: Summary of proceedings and voting results of the 8th Annual General Meeting held today With reference to our letter dated 26 August 2026, the 8th Annual General Meeting (AGM) of the Company was held today i.e. 17 September 2026 and the businesses mentioned in the Notice of AGM dated 5 August 2026 were transacted. In this regard, please find enclosed the following: 1. Summary of the proceedings of the AGM, as required under Regulation 30 and Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) enclosed as Annexure – I; 2. Voting results of e-Voting (prior to as well as during the meeting), in relation to the item of business transacted at the said Meeting, as required under Regulation 44(3) of the SEBI Listing Regulations, enclosed as Annexure- II; and 3. The Scrutinizer's Report dated 17 September 2026, pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 enclosed as Annexure- III. The above documents are being uploaded on the website of the Company. Kindly take the above record. Thanking you, Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K. Mishra Company Secretary and Compliance Officer Encl: as above Annexure – I Summary of proceedings of the 8th Annual General Meeting of the Company held on Thursday, 17 September 2026 at 04:00 p.m. (IST) The 8th Annual General Meeting of the Company was held on Thursday, 17 September 2026 at 04:00 p.m. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The Meeting commenced at 04:00 p.m. (IST) and concluded at 5:21 p.m. (IST) (including the time provided for e-voting at the AGM). Directors Present: 1. Mr. Umang Vohra Executive Chairman & Group CEO 2. Ms. Matangi Gowrishankar Independent Director and Chairperson of Nomination and Remuneration Committee 3. Mr. Vinod Rao Independent Director and Chairman of Audit Committee 4. Mr. KG Ananthakrishnan Independent Director, Chairman of Stakeholders Relationship Committee and Shareholder 5. Mr. Pravin Rao Independent Director 6. Mr. Jai Shankar Kishan Independent Director 7. Mr. Pankaj Patwari Non-Executive Director 8. Mr. Vinod Padikkal Non-Executive Director In attendance: 1. Mr. Sisir K. Mishra Company Secretary & Compliance Officer Others: 1. Representative of Statutory Auditors 2. Representative of Secretarial Auditors 3. Mrs. D Renuka, Practicing Company Secretary – Scrutinizer 4. Mr. Sudarsan Maddi, VP (F&A) of the Company Members Present: • No. of Shareholders on the cut-off date :97,424 • No. of Shareholders who attended the meeting through VC : 50 Pursuant to Article 72 of the Articles of Association of the Company, Mr. Umang Vohra, Executive Chairman & Group CEO of the Company took the chair and conducted the proceedings of the Meeting. The requisite quorum being present, the meeting was called to order. The Chairman delivered his speech. The Company Secretary informed the members that the meeting is being held through Video Conferencing/ Other Audio Visual Means (OAVM) in compliance with the applicable Circulars issued by the Ministry of Corporate Affairs (MCA) and Securities Exchange Board of India (SEBI). The members were informed that the Integrated Annual Report for the financial year 2025-26, comprising the Notice of AGM, Board’s Report, BRSR, Standalone and Consolidated Financial Statements along with Auditors Report thereon, has been sent through electronic mode to all the members who have registered their email addresses with their Depository Participants or with the Company or its Registrar & Transfer Agent. With the permission of the Members, the Notice convening the meeting and the Auditor’s Report were taken as read. The members were informed that the Statutory Auditors' Report and the Secretarial Auditor’s Report do not contain any qualification, observation or adverse remarks. The Company has engaged the services of KFin Technologies Limited (“KFintech”) to provide remote e- voting and e-voting facility during this AGM. The documents and registers, as referred to in the Notice of AGM, were made available electronically on KFintech e-voting portal for inspection by the members. The members were further informed that the Company has provided the members with a facility to cast their votes electronically, on all resolutions set forth in the Notice of the 8th AGM through remote e-voting provided by KFintech. The remote e-voting facility was open from Monday, 14 September 2026 at 9 a.m. (IST) to Wednesday, 16 September 2026 at 5 p.m. (IST). Members who attended the AGM and had not cast their votes through remote e-voting prior to the meeting were provided an opportunity to cast their votes during the AGM through the Insta Poll facility provided by KFintech. Members attending the AGM, who had registered themselves as speakers were given opportunity to ask questions or offer comments. The members provided suggestions and raised certain queries. The queries were responded by the Management. The following items of business, as per the Notice of the 8th AGM were transacted at the meeting: Ordinary Business: No Resolutions Type of resolution 1 Adoption of Standalone Financial Statements Ordinary 2 Adoption of Consolidated Financial Statements Ordinary 3 Reappointment of Ms. Shweta Jalan, Director liable to retire by rotation Ordinary Mr. Umang Vohra, Chairman informed the members that Mrs. D. Renuka, Practicing Company Secretary, was appointed as the Scrutinizer to scrutinize process of remote e-voting prior to the AGM and e-voting during the AGM in a fair and transparent manner and to report on the voting results for the items as per the notice of the 8th AGM. The Chairman authorized the Company Secretary, to declare the results of voting. As per the Scrutinizers' Report received all the resolutions set out in the Notice of the 8th AGM were passed by requisite majority. For Cohance Lifesciences Limited (Formerly, Suven Pharmaceuticals Limited) Sisir K. Mishra Company Secretary and Compliance Officer Annexure - II Annexure - III D. Renuka M.Com. ACS PRACTICING COMPANY SECRETARY Consolidated Scrutinizer [Pursuant to Section 108 of the Companies Act,2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 as amended from time to time] The Chairman 8th Annual General Meeting (AGM) of the equity shareholders of Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Registered Office: # 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala Midc, Mumbai- 400093, Maharashtra, India Dear Sir, Sub: Consolidated S Report for remote e-voting and e-voting during the 8th AGM 2026. ******* I, D. Renuka, Practicing Company Secretary, appointed as the Scrutinizer by the Board of Directors of Cohance Lifesciences Limited (formerly, Suven Pharmace to scrutinize the: a) remote e-voting process, pursuant to Section 108 of the Companies Act, 2013 ( the Act ) read with Rule 20 of the Companies (Management and Administration) Rules 2014, for the item nos.1 to 3 proposed as Ordinary Resolutions at the 8th AGM of the Equity Shareholders of the Company held on Thursday, September 17, 2026 at 4.00 p.m. IST. b) electronic voting system during the AGM through VC/OAVM, pursuant to circulars issued by the Ministry of Corporate Affairs (MCA) dated April 8, 2020, April 13, 2020, May 5, 2020, and subsequent circulars issued in this regard, the latest being 03/2025 dated September 22, 2025 ( hereinafter collectively referred as MCA Circulars ), and the provisions of the Securities and Exchange Board of India (Listing Obligations [Showing first 8,000 characters — download PDF for full document]